Welcome to our dedicated page for Youngevity Inter news (Ticker: YGYI), a resource for investors and traders seeking the latest updates and insights on Youngevity Inter stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Youngevity Inter's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Youngevity Inter's position in the market.
Youngevity International (NASDAQ: YGYI) received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to untimely filing of its Quarterly Report on Form 10-Q for the quarter ending June 30, 2020. The company has until September 28, 2020, to file all delinquent reports to avoid delisting. Additionally, previous notifications from Nasdaq highlighted failures in filing the Form 10-K for December 31, 2019, and the Form 10-Q for March 31, 2020. Management is actively working to rectify these filing issues.
Youngevity International (Nasdaq: YGYI) has announced a 5-year distribution agreement through its subsidiary CLR Roasters with H&H Coffee Group Export Corp. to sell its espresso brands, Café La Rica and Café Cachita, in Panama. The initial order consists of 60,000 units of Café Cachita Espresso, with a similar order for Café La Rica expected shortly after. This partnership could generate around $2 million in annual revenue, reflecting Youngevity's strategy to expand its international market presence.